HIV-1 amino acid changes among participants with virologic failure: associations with first-line efavirenz or atazanavir plus ritonavir and disease status.
about
HIV-1 Drug Resistance Mutations: Potential Applications for Point-of-Care Genotypic Resistance TestingGeographic and temporal trends in the molecular epidemiology and genetic mechanisms of transmitted HIV-1 drug resistance: an individual-patient- and sequence-level meta-analysisHIV-1 drug resistance and resistance testing.Global epidemiology of drug resistance after failure of WHO recommended first-line regimens for adult HIV-1 infection: a multicentre retrospective cohort studyPhylogenetic evidence of HIV-1 sequence evolution in subjects with persistent low-level viraemia.Human Immunodeficiency Virus-1 Sequence Changes and Drug Resistance Mutation Among Virologic Failures of Lopinavir/Ritonavir Monotherapy: AIDS Clinical Trials Group Protocol A5230.Strategic use of dual regimens of boosted protease inhibitors plus maraviroc in poorly adherent subjects in view of long-acting drugs: A retrospective study.Evolution of gag and gp41 in Patients Receiving Ritonavir-Boosted Protease Inhibitors.Human Immunodeficiency Virus Type 1 Drug Resistance Mutations Update.High rate of HIV-1 drug resistance in treatment failure patients in Taiwan, 2009-2014.Efavirenz Therapeutic Range in HIV-1 Treatment-Naive Participants.
P2860
Q28271593-35BDE656-94C0-4536-93E7-10D2757B2263Q28545866-FB98FB40-3020-4EAC-AFBE-21A81387D699Q30245693-718C0AE4-1516-4A55-8C02-794BEF346577Q30384060-5421A1E8-6B40-461A-9366-F98D73BE8CCBQ34289476-94DDF100-5525-4900-869E-214B5E674758Q37305622-D245C927-E14C-4D8D-8BB3-126C3C5AFA17Q38756649-91847246-7278-4FA0-9204-EC5A93EA326DQ40039995-7ADCBE87-3B70-4876-93C6-7F0BC8971209Q41926589-4EA3562F-421C-460F-AAFC-DB9E1C4AD7A2Q42649793-1B399511-FD46-42AC-9B1E-1CF8676D8FEEQ46600089-7D0F5683-0D96-49C2-B6DF-14877273535A
P2860
HIV-1 amino acid changes among participants with virologic failure: associations with first-line efavirenz or atazanavir plus ritonavir and disease status.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
HIV-1 amino acid changes among ...... ritonavir and disease status.
@ast
HIV-1 amino acid changes among ...... ritonavir and disease status.
@en
type
label
HIV-1 amino acid changes among ...... ritonavir and disease status.
@ast
HIV-1 amino acid changes among ...... ritonavir and disease status.
@en
prefLabel
HIV-1 amino acid changes among ...... ritonavir and disease status.
@ast
HIV-1 amino acid changes among ...... ritonavir and disease status.
@en
P2093
P2860
P356
P1476
HIV-1 amino acid changes among ...... ritonavir and disease status.
@en
P2093
AIDS Clinical Trials Group Study A5202 Team
Ann C Collier
Camlin Tierney
Christina M Lalama
David Katzenstein
Eric S Daar
Katie Mollan
Margaret A Fischl
Maya Balamane
Paul E Sax
P2860
P304
P356
10.1093/INFDIS/JIS613
P407
P577
2012-11-12T00:00:00Z